ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,068.50
0.03%
US Tech 100
21,138.80
-0.15%
다우존스 지수
44,593.65
0.28%
Bitcoin
96,098.79
0.36%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NYSE
  6. Glaukos Corporation (GKOS)

  7. Glaukos Corporation (GKOS) 뉴스

GKOS

Glaukos (GKOS)

Glaukos Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NYSE:GKOS
일자시간출처헤드라인심볼기업
2025/01/2508:33Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
2025/01/2321:00Business WireGlaukos to Release Fourth Quarter and Full Year 2024 Financial Results after Market Close on February 20NYSE:GKOSGlaukos Corporation
2025/01/1506:05Edgar (US Regulatory)Form 8-K - Current reportNYSE:GKOSGlaukos Corporation
2025/01/1506:05Business WireGlaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical PlatformNYSE:GKOSGlaukos Corporation
2025/01/0310:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
2025/01/0310:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
2025/01/0310:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
2025/01/0310:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
2024/12/2411:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
2024/12/2409:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
2024/12/2321:00Business WireGlaukos Submits New Drug Application to U.S. FDA for Epioxa™NYSE:GKOSGlaukos Corporation
2024/12/2106:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:GKOSGlaukos Corporation
2024/12/2106:21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:GKOSGlaukos Corporation
2024/12/1721:00Business WireGlaukos Announces Participation in the J.P. Morgan Healthcare ConferenceNYSE:GKOSGlaukos Corporation
2024/12/1409:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
2024/12/1202:32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:GKOSGlaukos Corporation
2024/12/0920:30Edgar (US Regulatory)Form 8-K - Current reportNYSE:GKOSGlaukos Corporation
2024/12/0320:02Edgar (US Regulatory)Form 8-K - Current reportNYSE:GKOSGlaukos Corporation
2024/11/1521:00Edgar (US Regulatory)Form 8-K - Current reportNYSE:GKOSGlaukos Corporation
2024/11/0821:00Business WireGlaukos Announces Participation in Upcoming Investor ConferencesNYSE:GKOSGlaukos Corporation
2024/11/0506:10Edgar (US Regulatory)Form 8-K - Current reportNYSE:GKOSGlaukos Corporation
2024/11/0506:05Business WireGlaukos Announces Third Quarter 2024 Financial ResultsNYSE:GKOSGlaukos Corporation
2024/11/0206:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
2024/10/3105:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:GKOSGlaukos Corporation
2024/10/1707:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
2024/10/1707:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
2024/10/1705:05Business WireGlaukos Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxa™, Achieving Primary Efficacy Endpoint and Demonstrating Favorable Tolerability and SafetyNYSE:GKOSGlaukos Corporation
2024/10/1420:00Business WireGlaukos To Present Multiple Scientific Abstracts at the 2024 American Academy of Ophthalmology Annual MeetingNYSE:GKOSGlaukos Corporation
2024/10/1206:27Edgar (US Regulatory)Form 8-K - Current reportNYSE:GKOSGlaukos Corporation
2024/10/0920:00Business WireGlaukos to Release Third Quarter 2024 Financial Results after Market Close on November 4NYSE:GKOSGlaukos Corporation
 검색 관련기사 보기:NYSE:GKOS

최근 히스토리

NYSE
XOM
Exxon Mobil
USOTC
BNPQY
BNP Paribas (QX)
COIN
BTCUSD
Bitcoin
NYSE
VZ
Verizon Communications
USOTC
BASFY
BASF (QX)
NYSE
BAC
Bank of America
NASDAQ
AMZN
Amazon.com
NYSE
KO
Coca Cola
NYSE
CVX
Chevron
NASDAQ
MSFT
Microsoft
COIN
DOGEUSD
Dogecoin
NASDAQ
TSLA
Tesla
CCOM
SILVER
SILVER
AMEX
SPY
SPDR S&P 500
NYSE
JPM
JP Morgan Chase
NASDAQ
QQQ
Invesco QQQ Trust Series 1
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지